GHMAP
Medical device registration pathways by country
Structured market-access overviews for primary and major markets — local representative rules, planning timelines, and submission steps. Planning intelligence only — not a regulatory determination or clinical decision support.
Timeline and fee figures on pathway pages are illustrative until primary sources are verified. Professional review is required before business use.
Active pathway pages
Focus regions include Türkiye, Middle East, Africa, Europe, the UK, the United States, and Canada.
Canada
Health Canada
European Union
EU MDR
Nigeria
NAFDAC
Saudi Arabia
SFDA
South Africa
SAHPRA
Türkiye
TİTCK
United Arab Emirates
MOHAP
United Kingdom
MHRA
United States
FDA
